Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Malignant Female Reproductive System Neoplasm × Enoxaparin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Venous Thromboembolism 3 Neoplasms 3 Venous Thrombosis 2 Carcinoma, Non-Small-Cell Lung 2 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Malignant Female Reproductive System Neoplasm 1 Abdominal Neoplasms 1

Interventions

Heparin 1 Enoxaparin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01356329 2016-05-13

Lovenox

National Guard Health Affairs

Phase 3 Suspended

Malignant Female Reproductive System Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon ⚡